XNCR

Xencor, Inc.
Data: 2026-02-02
$12.3
Price
1.74%
Change
$19.17
52W High
$6.92
52W Low

Xencor Inc a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases. The company uses its XmAb technology platform to create antibody product candidates. Its pipeline includes XmAb819, XmAb541, XmAb808, XmAb942, Plamotamab, and XmAb657. The group earns its revenue from collaboration agreements, product licensing agreements, and technology licensing agreements.

Quick Stats
Feb 02, 2026

49.0

AI Score

HOLD

0.28

Volume Ratio

Feb 26, 2026

Next Earnings

11

+ve Days (30d)

18

-ve Days (30d)

XNCR Stock Summary

Last updated Feb 02, 2026

XNCR is currently trading at $12.3, positioned above its 200-day moving average of $11.27, indicating a long-term uptrend. The stock has a 52-week range of $6.92 to $19.17.

Technical Analysis: The 50-day moving average stands at $15.13, which is above the current price, indicating bearish near-term pressure. The RSI (Relative Strength Index) reads 35.34, suggesting the stock is neutral with balanced momentum.

Money Flow Indicators: The Chaikin Money Flow (20-day) is -0.158, which is negative, suggesting distribution or selling pressure. Our AI-powered investment score rates XNCR at 49.0/100 with a HOLD recommendation.

XNCR (Xencor, Inc.) Indicators

Last updated Feb 02, 2026

Indicator Value
RSI(14) 35.34
CMF (20) -0.158
ROC (10) -3.831
ADX (14) 14.381
Indicator Value
MACD (12,26,9) -0.756
AROONOSC (14) -71.429
WILLAMS %R (14) -83.039
MFI (14) 39.419
XNCR Technical Chart
  • Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
  • SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
  • Options OI: Shows max open interest strikes. High OI = significant price levels.
  • Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
  • Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
  • Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
  • Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
  • Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators

Select indicators above to analyze technical patterns

Indicators will appear below the price chart with perfectly aligned dates

Volume Profile Analysis

Horizontal histogram showing volume distribution at each price level with buying/selling pressure

XNCR Price vs Max Options Open Interest
XNCR Max Change In Options Open Interest

XNCR Options - Sort by Max open Interest (near term)

2nd February 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

XNCR Daily Out of Money Options - Sort by Max open Interest (near term)

2nd February 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

XNCR Daily In the Money Options - Sort by Max open Interest (near term)

2nd February 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

XNCR Most Active Options by Volume(near term)

2nd February 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike Volume OI Change in
OI
Ask PC Delta Vega Volatility % change Track

Xencor, Inc. is not trading above both 50 Day and 200 Day SMA which is considered Bearish.

XNCR Moving Averages Analysis

Xencor, Inc. has been above 200 day sma 1 times in last 30 days. Last time it was above 200 day sma was on Feb 02, 2026

XNCR (Xencor, Inc.) Simple Moving Averages

Moving Averages are last updated Feb 02, 2026

Days MA
10 12.68
20 13.34
30 14.02
50 15.13
100 13.87
200 11.27

XNCR Fundamental Analysis

P/E (Forward) 0
P/E (Trailing) --
Market Cap ($) 863.4 million
Earnings/Share ($) -1.73
Net Proft Margin (%) -0.8714
Dividend/Share ($) --
EPS Estimate Current Year ($) -1.8269
EPS Estimate Next Year ($) -2.6212
WallStreet Target Price ($) 28.8333
Most Recent Quarter